WHO ICTRP trial
First-in-Human Study of DS-3939a in Subjects with Advanced Solid Tumors
JPRN-jRCT2031230233 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2031230233 |
|---|---|
| Public title | First-in-Human Study of DS-3939a in Subjects with Advanced Solid Tumors |
| Scientific title | PHASE 1/2, OPEN-LABEL, MULTICENTER, FIRST-IN-HUMAN STUDY OF DS-3939a IN SUBJECTS WITH ADVANCED SOLID TUMORS |
| Primary sponsor | Inoguchi Akihiro |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 1-2 |
| Countries | United States;Japan;Canada;Japan |
| Conditions | Locally advanced, metastatic, or unresectable solid tumors |
| Interventions | Generic name etc : DS-3939a Dosage and Administration for Investigational material : Dose Escalation Part : IV solution (Once every 3 weeks, initial dose 1 mg /kg), Dose Expansion Part : IV solution (Once every 3 weeks, recommended dose for… |
| Registration date | Jul 15, 2023 |
| Target size | 430 |
| Secondary IDs | NCT05875168 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: